Summary
In a significant market movement during January 2026, Oviva was the subject of a vc funding. The transaction achieved a gross valuation of £174,440,000. Leading the round was A.P. Moller Holding, Kinnevik, EGS Beteiligungen (EGSB), Lunate, Planet First Partners, Sofina, Norrsken VC.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
A.P. Moller Holding
Lead Investor / Acquirer
Kinnevik
Lead Investor / Acquirer
EGS Beteiligungen (EGSB)
Lead Investor / Acquirer
Lunate
Lead Investor / Acquirer
Planet First Partners
Lead Investor / Acquirer
Sofina
Lead Investor / Acquirer
Norrsken VC
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Growth prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in